# clinical-trial-stats

ä¸­æ–‡ | [English](README.en.md)

ä¸´åºŠè¯•éªŒæ ·æœ¬é‡è®¡ç®—ä¸ç»Ÿè®¡åˆ†æå·¥å…·åº“ã€‚

## åŠŸèƒ½

- **æ ·æœ¬é‡è®¡ç®—** â€” éåŠ£æ•ˆã€ä¼˜æ•ˆã€ç­‰æ•ˆ (TOST)ã€å•ç»„ã€é…å¯¹ (McNemar)ã€å¤šç»„ (Bonferroni)
- **ç»“æœéªŒè¯** â€” å‡è®¾æ£€éªŒï¼Œæ”¯æŒ Farrington-Manning RMLEã€Miettinen-Nurminenã€Wilson Score CI
- **ç½®ä¿¡åŒºé—´ä¼°ç®—** â€” ç‡çš„ CI (Wilson Score)ã€å‡å€¼çš„ CI (æ­£æ€è¿‘ä¼¼)
- **æ•ˆåº”é‡** â€” è¿ç»­ç»ˆç‚¹ Cohen's dã€ç‡ç»ˆç‚¹ Cohen's hï¼ˆåæ­£å¼¦å˜æ¢ï¼‰
- **æ•æ„Ÿæ€§åˆ†æ** â€” å‚æ•°æ‰«æï¼Œè§‚å¯Ÿæ ·æœ¬é‡éšå‚æ•°å˜åŒ–çš„è¶‹åŠ¿
- **åŒç»ˆç‚¹æ”¯æŒ** â€” æ¯ç§æ–¹æ³•å‡æ”¯æŒç‡ç»ˆç‚¹å’Œè¿ç»­ç»ˆç‚¹
- **é›¶ä¾èµ–** â€” çº¯ JavaScriptï¼Œå¯è¿è¡Œäº Node.jsã€æµè§ˆå™¨æˆ–ä»»ä½• JS ç¯å¢ƒ

## å¼€å‘è¿›åº¦

| æ¨¡å— | ç‡ç»ˆç‚¹ | è¿ç»­ç»ˆç‚¹ | æµ‹è¯• | å¯¹ç…§éªŒè¯ |
|------|:------:|:--------:|:----:|----------|
| **æ ·æœ¬é‡è®¡ç®—** | | | | |
| éåŠ£æ•ˆï¼ˆä¸¤ç»„ï¼‰ | âœ… | âœ… | âœ… | â€” |
| ä¼˜æ•ˆï¼ˆä¸¤ç»„ï¼‰ | âœ… | âœ… | âœ… | â€” |
| ç­‰æ•ˆ / TOSTï¼ˆä¸¤ç»„ï¼‰ | âœ… | âœ… | âœ… | â€” |
| å•ç»„è¯•éªŒ | âœ… | âœ… | ğŸ”² | â€” |
| é…å¯¹è®¾è®¡ | âœ… | âœ… | ğŸ”² | â€” |
| å¤šç»„æ¯”è¾ƒ | âœ… | âœ… | ğŸ”² | â€” |
| **ç»“æœéªŒè¯** | | | | |
| ä¸¤ç»„ï¼ˆWald / FM / MNï¼‰ | âœ… | âœ… | ğŸ”² | â€” |
| å•ç»„ | âœ… | âœ… | ğŸ”² | â€” |
| é…å¯¹ | âœ… | âœ… | ğŸ”² | â€” |
| å¤šç»„ | âœ… | âœ… | ğŸ”² | â€” |
| **å…¶ä»–æ¨¡å—** | | | | |
| ç‡çš„ç½®ä¿¡åŒºé—´ (Wilson Score) | âœ… | â€” | ğŸ”² | â€” |
| å‡å€¼ç½®ä¿¡åŒºé—´ | â€” | âœ… | ğŸ”² | â€” |
| æ•ˆåº”é‡ (Cohen's d / h) | âœ… | âœ… | âœ… | â€” |
| æ•æ„Ÿæ€§åˆ†æ | âœ… | âœ… | ğŸ”² | â€” |
| å†…éƒ¨ä¾èµ–ï¼šæ­£æ€åˆ†å¸ƒå‡½æ•°ã€æµ®ç‚¹ç²¾åº¦å¤„ç† | â€” | â€” | âœ… | â€” |

âœ… å·²å®Œæˆ &emsp; ğŸ”² å¾…è¡¥å…… &emsp; **å¯¹ç…§éªŒè¯**ï¼šç”¨äºäº¤å‰éªŒè¯çš„ç¬¬ä¸‰æ–¹è½¯ä»¶ï¼ˆå¦‚ Rã€SASã€PASSï¼‰ï¼Œæ¯å®Œæˆä¸€é¡¹æ­£å¼æµ‹è¯•åæ›´æ–°

## å®‰è£…

```bash
npm install clinical-trial-stats
```

## å¿«é€Ÿå¼€å§‹

```javascript
import {
  calculateNISampleSize,
  calculateSupSampleSize,
  calculateEqSampleSize
} from 'clinical-trial-stats'

// éåŠ£æ•ˆè¯•éªŒï¼ˆç‡ç»ˆç‚¹ï¼‰
// å¯¹ç…§ç»„: 85%, è¯•éªŒç»„: 85%, ç•Œå€¼: 10%, Alpha: 2.5%ï¼ˆå•ä¾§ï¼‰, æ•ˆèƒ½: 80%
const ni = calculateNISampleSize(0.85, 0.85, 0.1, 0.025, 0.8, 1)
// => { n1: 284, n2: 284 }

// ä¼˜æ•ˆè¯•éªŒï¼ˆç‡ç»ˆç‚¹ï¼‰
// å¯¹ç…§ç»„: 70%, è¯•éªŒç»„: 85%, Alpha: 2.5%, æ•ˆèƒ½: 80%
const sup = calculateSupSampleSize(0.70, 0.85, 0.025, 0.8, 1)
// => { n1: 71, n2: 71 }

// ç­‰æ•ˆè¯•éªŒï¼ˆTOSTï¼Œç‡ç»ˆç‚¹ï¼‰
// ä¸¤ç»„å‡ä¸º: 30%, ç­‰æ•ˆç•Œå€¼: 5%, Alpha: 2.5%, æ•ˆèƒ½: 80%
const eq = calculateEqSampleSize(0.3, 0.3, 0.05, 0.025, 0.8, 1)
// => { n1: 832, n2: 832 }
```

## API

### æ ·æœ¬é‡è®¡ç®—

| å‡½æ•° | è¯´æ˜ |
|------|------|
| `calculateNISampleSize(p1, p2, delta, alpha, power, ratio)` | éåŠ£æ•ˆï¼Œç‡ç»ˆç‚¹ |
| `calculateNISampleSizeContinuous(sigma, delta, alpha, power, ratio, meanDiff)` | éåŠ£æ•ˆï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateSupSampleSize(p1, p2, alpha, power, ratio)` | ä¼˜æ•ˆï¼Œç‡ç»ˆç‚¹ |
| `calculateSupSampleSizeContinuous(sigma, meanDiff, alpha, power, ratio)` | ä¼˜æ•ˆï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateEqSampleSize(p1, p2, delta, alpha, power, ratio)` | ç­‰æ•ˆ (TOST)ï¼Œç‡ç»ˆç‚¹ |
| `calculateEqSampleSizeContinuous(sigma, delta, alpha, power, ratio, meanDiff)` | ç­‰æ•ˆ (TOST)ï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateOneSampleSize(p0, p1, alpha, power)` | å•ç»„ï¼Œç‡ç»ˆç‚¹ |
| `calculateOneSampleSizeContinuous(mu0, mu1, sigma, alpha, power)` | å•ç»„ï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculatePairedSampleSize(p10, p01, delta, alpha, power, studyType)` | é…å¯¹ (McNemar)ï¼Œç‡ç»ˆç‚¹ |
| `calculatePairedSampleSizeContinuous(sigma_diff, mean_diff, delta, alpha, power, studyType)` | é…å¯¹ t æ£€éªŒï¼Œè¿ç»­ç»ˆç‚¹ |
| `calculateMultigroupSampleSize(p0, p_groups, delta, alpha, power, studyType, allocations, strategy)` | å¤šç»„ï¼Œç‡ç»ˆç‚¹ |
| `calculateMultigroupSampleSizeContinuous(mean0, mean_groups, sd, delta, alpha, power, studyType, allocations, strategy)` | å¤šç»„ï¼Œè¿ç»­ç»ˆç‚¹ |

### ç»“æœéªŒè¯ï¼ˆå‡è®¾æ£€éªŒï¼‰

| å‡½æ•° | è¯´æ˜ |
|------|------|
| `calculateNIResult(n1, x1, n2, x2, delta, alpha)` | éåŠ£æ•ˆæ£€éªŒ |
| `calculateSupResult(n1, x1, n2, x2, alpha)` | ä¼˜æ•ˆæ£€éªŒ |
| `calculateEqResult(n1, x1, n2, x2, delta, alpha)` | ç­‰æ•ˆæ£€éªŒ |
| `calculateOneSampleResult(n, s, p0, alpha, useContinuity)` | å•ç»„æ£€éªŒ |
| `calculatePairedResult(n10, n01, delta, alpha, useContinuity, studyType)` | é…å¯¹æ£€éªŒ (McNemar) |
| `calculateMultigroupResult(n0, x0, n_groups, x_groups, delta, alpha, studyType, allocations, strategy)` | å¤šç»„æ£€éªŒ |

æ‰€æœ‰ç»“æœéªŒè¯å‡½æ•°å‡æœ‰è¿ç»­ç»ˆç‚¹ç‰ˆæœ¬ï¼ˆå‡½æ•°åæœ«å°¾åŠ  `Continuous`ï¼‰ã€‚

### ç½®ä¿¡åŒºé—´ä¼°ç®—

| å‡½æ•° | è¯´æ˜ |
|------|------|
| `calculateRateCISampleSize(p, width, alpha)` | ç‡çš„ CI æ‰€éœ€æ ·æœ¬é‡ |
| `calculateRateCI(n, x, alpha)` | ç‡çš„ç½®ä¿¡åŒºé—´ (Wilson Score) |
| `calculateMeanCISampleSize(sigma, width, alpha)` | å‡å€¼ CI æ‰€éœ€æ ·æœ¬é‡ |
| `calculateMeanCI(n, mean, sd, alpha)` | å‡å€¼ç½®ä¿¡åŒºé—´ |

### æ•ˆåº”é‡

| å‡½æ•° | è¯´æ˜ |
|------|------|
| `calculateCohenD(meanDiff, sigma)` | è¿ç»­ç»ˆç‚¹æ•ˆåº”é‡ (Cohen's d) |
| `calculateCohenH(p1, p2)` | ç‡ç»ˆç‚¹æ•ˆåº”é‡ (Cohen's h) |
| `interpretCohenD(d)` | æ•ˆåº”é‡ç­‰çº§è§£è¯» |
| `getEffectSizeInfo(meanDiff, sigma)` | å®Œæ•´æ•ˆåº”é‡æŠ¥å‘Š |

### æ•æ„Ÿæ€§åˆ†æ

| å‡½æ•° | è¯´æ˜ |
|------|------|
| `runSensitivityAnalysis(mode, baseParams, config)` | å‚æ•°æ‰«æåˆ†æ |

### æ ¸å¿ƒå·¥å…·

| å‡½æ•° | è¯´æ˜ |
|------|------|
| `normalCDF(x)` | æ ‡å‡†æ­£æ€åˆ†å¸ƒç´¯ç§¯åˆ†å¸ƒå‡½æ•° |
| `normalInverse(p)` | æ­£æ€åˆ†å¸ƒé€†å‡½æ•°ï¼ˆåˆ†ä½æ•°å‡½æ•°ï¼‰ |

## å‚æ•°è¯´æ˜

æ‰€æœ‰ç‡å‚æ•°ä½¿ç”¨**å°æ•°åˆ¶** (0-1)ï¼Œè€Œéç™¾åˆ†æ¯”ï¼š

- `p1 = 0.85` è¡¨ç¤º 85%
- `alpha = 0.025` è¡¨ç¤ºå•ä¾§ 2.5%
- `power = 0.8` è¡¨ç¤º 80%
- `delta = 0.1` è¡¨ç¤º 10% ç•Œå€¼
- `ratio` = åˆ†é…æ¯”ä¾‹ n2/n1ï¼ˆé»˜è®¤ 1:1 ç­‰æ¯”åˆ†é…ï¼‰

## å…¬å¼

### éåŠ£æ•ˆï¼ˆä¸¤ç»„æ¯”è¾ƒï¼‰

**ç‡ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{[(p_2 - p_1) + \delta]^2}$$

**è¿ç»­ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma^2 \cdot (1 + 1/k)}{[(\mu_2 - \mu_1) + |\delta|]^2}$$

> Chow et al. (2017) Chapter 4; Julious & Campbell (2012) *Stat Med* 31:2904-2936

### ä¼˜æ•ˆï¼ˆä¸¤ç»„æ¯”è¾ƒï¼‰

**ç‡ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{(p_2 - p_1)^2}$$

**è¿ç»­ç»ˆç‚¹ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma^2 \cdot (1 + 1/k)}{(\mu_2 - \mu_1)^2}$$

> Chow et al. (2017) Chapter 4

### ç­‰æ•ˆ â€” TOSTï¼ˆä¸¤ç»„æ¯”è¾ƒï¼‰

æ ¹æ®é¢„æœŸå·®å¼‚æ˜¯å¦ä¸ºé›¶ï¼ŒåŠ¨æ€é€‰æ‹© Z å€¼ï¼š

**å½“ pâ‚ = pâ‚‚ï¼ˆå¯¹ç§° TOSTï¼‰ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta/2})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{\delta^2}$$

**å½“ pâ‚ â‰  pâ‚‚ï¼ˆéå¯¹ç§° TOSTï¼‰ï¼š**

$$n_1 = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot [p_1(1-p_1) + p_2(1-p_2)/k]}{[\delta - |p_2 - p_1|]^2}$$

> Julious (2009) Chapter 6; Flight & Julious (2016) *Pharm Stat* 15(1):80-89; Phillips (1990) *J Pharmacokinet Biopharm* 18(2):137-144

### å•ç»„è¯•éªŒ

**ç‡ç»ˆç‚¹ï¼š**

$$n = \frac{[Z_{1-\alpha}\sqrt{p_0(1-p_0)} + Z_{1-\beta}\sqrt{p_1(1-p_1)}]^2}{(p_1 - p_0)^2}$$

**è¿ç»­ç»ˆç‚¹ï¼š**

$$n = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma^2}{(\mu_1 - \mu_0)^2}$$

### é…å¯¹è®¾è®¡

**ç‡ç»ˆç‚¹ï¼ˆMcNemar æ£€éªŒï¼‰ï¼š**

$$n = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot (p_{10} + p_{01})}{(p_{10} - p_{01} - \delta)^2}$$

å…¶ä¸­ pâ‚â‚€ å’Œ pâ‚€â‚ ä¸ºä¸ä¸€è‡´é…å¯¹çš„æ¯”ä¾‹ã€‚

**è¿ç»­ç»ˆç‚¹ï¼ˆé…å¯¹ t æ£€éªŒï¼‰ï¼š**

$$n = \frac{(Z_{1-\alpha} + Z_{1-\beta})^2 \cdot \sigma_{diff}^2}{\text{effect size}^2}$$

### å¤šç»„æ¯”è¾ƒï¼ˆBonferroni æ ¡æ­£ï¼‰

å¯¹å¤šé‡æ¯”è¾ƒè¿›è¡Œ Bonferroni æ ¡æ­£ï¼š

$$\alpha_{adjusted} = \alpha / k \quad \text{(strategy = 'any')}$$

$$n_i = \frac{(Z_{1-\alpha_{adj}} + Z_{1-\beta})^2 \cdot [p_0(1-p_0)/r_0 + p_i(1-p_i)/r_i]}{\text{effect size}^2}$$

æ”¯æŒé€šè¿‡æƒé‡æ•°ç»„ `[râ‚€, râ‚, râ‚‚, ...]` è¿›è¡Œä¸ç­‰æ¯”ä¾‹åˆ†é…ã€‚

### ç½®ä¿¡åŒºé—´

**ç‡ï¼ˆWilson Score æ³•ï¼‰ï¼š**

$$n \approx \frac{Z^2 \cdot p(1-p)}{w^2}$$

**å‡å€¼ï¼š**

$$n = \left(\frac{Z \cdot \sigma}{w}\right)^2$$

### æ•ˆåº”é‡

**Cohen's d**ï¼ˆè¿ç»­ç»ˆç‚¹ï¼‰: $\quad d = \dfrac{\mu_1 - \mu_2}{\sigma}$

**Cohen's h**ï¼ˆç‡ç»ˆç‚¹ï¼‰: $\quad h = 2[\arcsin(\sqrt{p_1}) - \arcsin(\sqrt{p_2})]$

è§£è¯»ï¼šæå° (<0.2)ã€å° (0.2â€“0.5)ã€ä¸­ (0.5â€“0.8)ã€å¤§ (â‰¥0.8)

### ç»“æœéªŒè¯

ä¸¤ç»„ç‡ç»ˆç‚¹çš„å‡è®¾æ£€éªŒæ”¯æŒä¸‰ç§æ–¹æ³•ï¼š

| æ–¹æ³• | è¯´æ˜ | å‚è€ƒæ–‡çŒ® |
|------|------|----------|
| **Wald** | åŸºäºè§‚æµ‹ç‡çš„æ­£æ€è¿‘ä¼¼ | ç»å…¸æ–¹æ³• |
| **Farrington-Manning** | Hâ‚€ çº¦æŸä¸‹çš„ RMLEï¼ŒNewton-Raphson è¿­ä»£ | Farrington & Manning (1990) |
| **Miettinen-Nurminen** | Score æ³•ï¼Œä¸ SAS PROC FREQ ç»“æœä¸€è‡´ | Miettinen & Nurminen (1985) *Stat Med* |

## å‚è€ƒæ–‡çŒ®

1. Chow SC, Shao J, Wang H, Lokhnygina Y. *Sample Size Calculations in Clinical Research*. 3rd ed. Chapman and Hall/CRC; 2017.
2. Julious SA. *Sample Sizes for Clinical Trials*. Chapman and Hall/CRC; 2009.
3. Flight L, Julious SA. Practical guide to sample size calculations: non-inferiority and equivalence trials. *Pharm Stat*. 2016;15(1):80-89.
4. Julious SA, Campbell MJ. Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data. *Stat Med*. 2012;31:2904-2936.
5. Phillips KF. Power of the Two One-Sided Tests Procedure in Bioequivalence. *J Pharmacokinet Biopharm*. 1990;18(2):137-144.
6. Miettinen O, Nurminen M. Comparative analysis of two rates. *Stat Med*. 1985;4(2):213-226.
7. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. *Stat Med*. 1990;9(12):1447-1454.
8. Newcombe RG. Interval estimation for the difference between independent proportions. *Stat Med*. 1998;17(8):873-890.
9. NMPA. è¯ç‰©ä¸´åºŠè¯•éªŒæ ·æœ¬é‡ä¼°è®¡æŒ‡å¯¼åŸåˆ™ (2023).

## ç®—æ³•å®¡è®¡

æœ¬é¡¹ç›®çš„å…¨éƒ¨è®¡ç®—ç®—æ³•å·²é€šè¿‡ç‹¬ç«‹å®¡è®¡ï¼Œå¯¹æ ‡ä»¥ä¸‹ 7 ä¸ªå¼€æºç»Ÿè®¡åº“ï¼š

| å¯¹æ ‡åº“ | æ ¸å¿ƒä»·å€¼ |
|--------|---------|
| [gsDesign](https://github.com/keaven/gsDesign) (R) | é»˜æ²™ä¸œç»´æŠ¤ï¼ŒFM å—çº¦æŸ MLE æ–¹å·®ï¼Œç«äº‰é£é™©è„±è½æ¨¡å‹ |
| [statsmodels](https://github.com/statsmodels/statsmodels) (Python) | å·¥ä¸šçº§ Brent æ±‚è§£å™¨ï¼Œä¸‰çº§å›é€€æœºåˆ¶ |
| [G\*Power 3.1](https://www.psychologie.hhu.de/arbeitsgruppen/allgemeine-psychologie-und-arbeitspsychologie/gpower) | å…¨çƒç›‘ç®¡å…¬è®¤ç²¾åº¦é‡‘æ ‡å‡†ï¼Œéä¸­å¿ƒåˆ†å¸ƒç²¾ç¡®è®¡ç®— |
| [pwr](https://github.com/cran/pwr) (R) | Cohen æ•ˆèƒ½ç†è®ºæ ‡å‡†å®ç°ï¼Œéä¸­å¿ƒ t åˆ†å¸ƒ |
| [TrialSize](https://github.com/cran/TrialSize) (R) | ä¸´åºŠæ ·æœ¬é‡ç™¾ç§‘å…¨ä¹¦ï¼Œå« TOST / McNemar |
| [SampleSize4ClinicalTrials](https://github.com/QiHongchao/SampleSize4ClinicalTrials) (R) | III æœŸä¸´åºŠ Delta è¾¹é™…å¤„ç† |
| [precisely](https://github.com/malcolmbarrett/precisely) (R) | CI å®½åº¦é©±åŠ¨çš„ç²¾åº¦è®¡ç®— |

å®¡è®¡ç»´åº¦è¦†ç›–ï¼šè¾¹ç•Œé˜²å¾¡ã€æ•°å€¼ç¨³å®šæ€§ã€æ±‚è§£å™¨ç²¾åº¦ã€æ–¹å·®æ¨¡å‹ã€æ•ˆåº”é‡å¤„ç†ã€ç›‘ç®¡åˆè§„æ€§ã€‚

å®Œæ•´å®¡è®¡æŠ¥å‘Šï¼š[docs/audit/](docs/audit/)

## æµ‹è¯•

```bash
npm test
```

æµ‹è¯•ç”¨ä¾‹åŸºäºå·²å‘è¡¨æ–‡çŒ®ç»“æœå’Œæˆç†Ÿç»Ÿè®¡è½¯ä»¶ï¼ˆRã€SASï¼‰è¿›è¡Œäº¤å‰éªŒè¯ã€‚

## å…³äº

æœ¬é¡¹ç›®ç”± **ææ’éª** ([lihj.net](https://lihj.net)) ä¸ [Claude Code](https://claude.ai/claude-code) (Anthropic) å…±åŒå®Œæˆã€‚

æœ¬é¡¹ç›®é€šè¿‡äººæœºåä½œå®Œæˆã€‚ä½œè€…æä¾›ä¸´åºŠè¯•éªŒé¢†åŸŸä¸“ä¸šçŸ¥è¯†ï¼Œä¸»å¯¼æ‰€æœ‰è®¾è®¡å†³ç­–ï¼Œå¹¶åŸºäºåŒè¡Œè¯„å®¡æ–‡çŒ®éªŒè¯è®¡ç®—ç»“æœçš„æ­£ç¡®æ€§ã€‚Claude Code è´Ÿè´£ç®—æ³•å®ç°ä¸æµ‹è¯•ç¼–å†™ã€‚

## è®¸å¯è¯

[MIT](LICENSE)
